‘A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer’

This phase II trial was performed to evaluate the efficacy and tolerability of a new combination of Uracil/Ftorafur (UFT®)/leucovorin (LV) and oxaliplatin in patients (pts) with metastatic colorectal cancer (MCRC) who had not received prior chemotherapy for metastatic disease. Between February 2002...

Descripción completa

Detalles Bibliográficos
Autores principales: Bennouna, J, Perrier, H, Paillot, B, Priou, F, Jacob, J H, Hebbar, M, Bordenave, S, Seitz, J F, Cvitkovic, F, Dorval, E, Malek, K, Tonelli, D, Douillard, J Y
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361076/
https://www.ncbi.nlm.nih.gov/pubmed/16404362
http://dx.doi.org/10.1038/sj.bjc.6602913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361076/
https://www.ncbi.nlm.nih.gov/pubmed/16404362
http://dx.doi.org/10.1038/sj.bjc.6602913

Ejemplares similares